France Osteoarthritis Injectables Market Size & Outlook
Related Markets
France osteoarthritis injectables market highlights
- The France osteoarthritis injectables market generated a revenue of USD 262.1 million in 2025 and is expected to reach USD 405.9 million by 2033.
- The France market is expected to grow at a CAGR of 5.7% from 2026 to 2033.
- In terms of segment, knee osteoarthritis was the largest revenue generating anatomy in 2025.
- Hip Osteoarthritis is the most lucrative anatomy segment registering the fastest growth during the forecast period.
Osteoarthritis injectables market data book summary
| Market revenue in 2025 | USD 262.1 million |
| Market revenue in 2033 | USD 405.9 million |
| Growth rate | 5.7% (CAGR from 2026 to 2033) |
| Largest segment | Knee osteoarthritis |
| Fastest growing segment | Hip Osteoarthritis |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Knee Osteoarthritis, Hand Osteoarthritis, Others Anatomy, Hip Osteoarthritis |
| Key market players worldwide | Anika Therapeutics Inc, Bioventus Inc Class A, Ferring, Sanofi SA, Zimmer Biomet Holdings Inc, Arthrex, Pacira BioSciences Inc, Royal Biologics, Teva Pharmaceutical Industries Ltd |
Other key industry trends
- In terms of revenue, France accounted for 3.2% of the global osteoarthritis injectables market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany osteoarthritis injectables market is projected to lead the regional market in terms of revenue in 2033.
- Denmark is the fastest growing regional market in Europe and is projected to reach USD 52.0 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Osteoarthritis Injectables Market Scope
Osteoarthritis Injectables Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Royal Biologics | View profile | 11-50 | Hackensack, New Jersey, United States, North America | https://royalbiologics.com |
| Pacira BioSciences Inc | View profile | 712 | 5401 West Kennedy Boulevard, Suite 890, Tampa, FL, United States, 33609 | https://www.pacira.com |
| Arthrex | View profile | 5001-10000 | Naples, Florida, United States, North America | https://www.arthrex.com/ |
| Ferring | View profile | 5001-10000 | Saint-prex, Vaud, Switzerland, Europe | https://www.ferring.com |
| Bioventus Inc Class A | View profile | 995 | 4721 Emperor Boulevard, Suite 100, Durham, NC, United States, 27703 | https://www.bioventus.com |
| Anika Therapeutics Inc | View profile | 357 | 32 Wiggins Avenue, Bedford, MA, United States, 01730 | https://www.anika.com |
| Zimmer Biomet Holdings Inc | View profile | 18000 | 345 East Main Street, Warsaw, IN, United States, 46580 | https://www.zimmerbiomet.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
France osteoarthritis injectables market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to osteoarthritis injectables market will help companies and investors design strategic landscapes.
Knee osteoarthritis was the largest segment with a revenue share of 44.49% in 2025. Horizon Databook has segmented the France osteoarthritis injectables market based on knee osteoarthritis, hand osteoarthritis, others anatomy, hip osteoarthritis covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to France osteoarthritis injectables market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France osteoarthritis injectables market databook
-
Our clientele includes a mix of osteoarthritis injectables market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France osteoarthritis injectables market , including forecasts for subscribers. This country databook contains high-level insights into France osteoarthritis injectables market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
France osteoarthritis injectables market size, by injection type, 2021-2033 (US$M)
France Osteoarthritis Injectables Market Outlook Share, 2025 & 2033 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
